Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)

Exclusive Premium Statistic

Novartis' top drugs based on revenue 2018 This statistic depicts Novartis AG's top 10 drugs based on revenue in 2018. Novartis is a Swiss-based global pharmaceutical company. In that year, Novartis' drug Tasigna generated some 1.87 billion U.S. dollars of revenue. Since several years, Gleevec (glivec) is one of Novartis' top pharmaceutical product based on revenue. Gleevec is a drug for the treatment of several types of cancer.
Show more
Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic depicts Novartis AG's top 10 drugs based on revenue in 2018. Novartis is a Swiss-based global pharmaceutical company. In that year, Novartis' drug Tasigna generated some 1.87 billion U.S. dollars of revenue. Since several years, Gleevec (glivec) is one of Novartis' top pharmaceutical product based on revenue. Gleevec is a drug for the treatment of several types of cancer.
Show more
Release date
January 2019
Region
Worldwide
Survey time period
2018
Open this statistic in...
More information
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Top pharmaceutical drugs
Top pharmaceutical drugs

All Information
in one Presentation

Top pharmaceutical drugs

Everything On "Top pharmaceutical drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Novartis"
  • Global positioning
  • Company overview
  • Revenue distribution
The most important statistics
  • Research and development
  • Miscellaneous
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics on the topic
Topics
About Statista
Learn more about how Statista can support your business.
Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News